| HORSKÁ, Kateřina, Jan KUČERA, Eva DRAŽANOVÁ, Gabriela KUZMÍNOVÁ, Petra AMCHOVÁ, Mária HRICKOVÁ, Jana RUDÁ a Silje SKREDE. Potent synergistic effects of dulaglutide and food restriction in prevention of olanzapine-induced metabolic adverse effects in a rodent model. Biomedicine and Pharmacotherapy. ISSY-LES-MOULINEAUX: Elsevier, 2024, roč. 176, July 2024, s. 1-11. ISSN 0753-3322. Dostupné z: https://dx.doi.org/10.1016/j.biopha.2024.116763. |
Další formáty:
BibTeX
LaTeX
RIS
@article{2405317,
author = {Horská, Kateřina and Kučera, Jan and Dražanová, Eva and Kuzmínová, Gabriela and Amchová, Petra and Hricková, Mária and Rudá, Jana and Skrede, Silje},
article_location = {ISSY-LES-MOULINEAUX},
article_number = {July 2024},
doi = {http://dx.doi.org/10.1016/j.biopha.2024.116763},
keywords = {Antipsychotic; Olanzapine; metabolic adverse effects; GLP-1 receptor agonist; Schizophrenia},
language = {eng},
issn = {0753-3322},
journal = {Biomedicine and Pharmacotherapy},
title = {Potent synergistic effects of dulaglutide and food restriction in prevention of olanzapine-induced metabolic adverse effects in a rodent model},
url = {https://www.sciencedirect.com/science/article/pii/S0753332224006474},
volume = {176},
year = {2024}
}
TY - JOUR
ID - 2405317
AU - Horská, Kateřina - Kučera, Jan - Dražanová, Eva - Kuzmínová, Gabriela - Amchová, Petra - Hricková, Mária - Rudá, Jana - Skrede, Silje
PY - 2024
TI - Potent synergistic effects of dulaglutide and food restriction in prevention of olanzapine-induced metabolic adverse effects in a rodent model
JF - Biomedicine and Pharmacotherapy
VL - 176
IS - July 2024
SP - 1-11
EP - 1-11
PB - Elsevier
SN - 07533322
KW - Antipsychotic
KW - Olanzapine
KW - metabolic adverse effects
KW - GLP-1 receptor agonist
KW - Schizophrenia
UR - https://www.sciencedirect.com/science/article/pii/S0753332224006474
N2 - A combined strategy of dulaglutide and food restriction manifested a massive synergistic benefit. GLP-1RAs represent a promising strategy and deserve thorough future research. Our findings underline the potential importance of lifestyle intervention in addition to GLP-1 RA treatment.
ER -
HORSKÁ, Kateřina, Jan KUČERA, Eva DRAŽANOVÁ, Gabriela KUZMÍNOVÁ, Petra AMCHOVÁ, Mária HRICKOVÁ, Jana RUDÁ a Silje SKREDE. Potent synergistic effects of dulaglutide and food restriction in prevention of olanzapine-induced metabolic adverse effects in a rodent model. \textit{Biomedicine and Pharmacotherapy}. ISSY-LES-MOULINEAUX: Elsevier, 2024, roč.~176, July 2024, s.~1-11. ISSN~0753-3322. Dostupné z: https://dx.doi.org/10.1016/j.biopha.2024.116763.
|
